Downregulation of H19 affects PCOS, including amelioration of hyperandrogenemia [20], inhibition of matrix metalloproteinases (MMPs) associated with ovarian remodeling [21, 22], and inhibition of granulosa cell proliferation [23]. Here, H19 is linked to polycystic ovary syndrome.